89Zr anti-CD44 immuno-PET monitors  CD44 expression on splenic myeloid cells and HT29 colon cancer cells

by Jin Won Park, Kyung-Ho Jung, Jin Hee Lee, Seung Hwan Moon, Young Seok Cho, Kyung-Han Lee
Published 2021

Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation

by Yong-Jin Park, Seung Hyup Hyun, Seung Hwan Moon, Kyung-Han Lee, Byung Hoon Min, Jun Haeng Lee, Won Seog Kim, Seok Jin Kim, Joon Young Choi
Published 2021

Author Correction: Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments

by Soo Hyun Cho, Yeong Sim Choe, Young Ju Kim, Byungju Lee, Hee Jin Kim, Hyemin Jang, Jun Pyo Kim, Young Hee Jung, Soo-Jong Kim, Byeong C. Kim, Gill Farrar, Duk L. Na, Seung Hwan Moon, Sang Won Seo
Published 2021

A missense variant in SHARPIN mediates Alzheimer’s disease-specific brain damages

by Jun Young Park, Dongsoo Lee, Jang Jae Lee, Jungsoo Gim, Tamil Iniyan Gunasekaran, Kyu Yeong Choi, Sarang Kang, Ah Ra Do, Jinyeon Jo, Juhong Park, Kyungtaek Park, Donghe Li, Sanghun Lee, Hoowon Kim, Immanuel Dhanasingh, Suparna Ghosh, Seula Keum, Jee Hye Choi, Gyun Jee Song, Lee Sael, Sangmyung Rhee, Simon Lovestone, Eunae Kim, Seung Hwan Moon, Byeong C. Kim, SangYun Kim, Andrew J. Saykin, Kwangsik Nho, Sung Haeng Lee, Lindsay A. Farrer, Gyungah R. Jun, Sungho Won, Kun Ho Lee, for the Alzheimer’s Disease Neuroimaging Initiative
Published 2021